India Pharma Outlook Team | Wednesday, 05 March 2025
Glenmark Pharmaceuticals Ltd's share price is trading at Rs 1380.8, up 3.49% on the day as of 12:49 eastern standard time on NSE. The stock has arisen significantly in the past year at 49.05% against the backdrop of NIFTY crashing down 0.46% well, and the Nifty Pharma Index dipping from its high to record in negative 4.57% in theirs truly account.
This compounded by it marking Glenmark's third consecutive day of gains shows that momentum may be in favor of the stock. The broader market saw similar positive movement, with the NIFTY rallying around 1.3%, quoted at 22,369.85, and the Sensex up by 1.19%, quoted at 73,855.47.
Glenmark Pharma also lost 7.94% in share price in the month against the Nifty Pharma Index, which besides Glenmark too lost 9.06% in same duration, although it went up 0.98% today at the level of 19,820.65. Today's volume of shares traded is 4.31 lakh, much lesser than the monthly average of 7.38 lakh shares.
March futures were quoted for Glenmark Pharmaceuticals at Rs 1384.75, up 3.52% today. The trailing twelve months price/earnings ratio calculated as of December 24 for the stock is 16.33. The Nifty Pharma Index, which includes Glenmark, has had a very challenging month of decline compared with its peers, dropping 9.06%, to socio-economic sectoral pressures behind it.